Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Total Liabilities (2016 - 2026)

Integra Lifesciences Holdings' Total Liabilities history spans 17 years, with the latest figure at $2.6 billion for Q4 2025.

  • On a quarterly basis, Total Liabilities rose 2.66% to $2.6 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $2.6 billion, a 2.66% increase, with the full-year FY2025 number at $2.6 billion, up 2.66% from a year prior.
  • Total Liabilities hit $2.6 billion in Q4 2025 for Integra Lifesciences Holdings, down from $2.6 billion in the prior quarter.
  • Over the last five years, Total Liabilities for IART hit a ceiling of $2.6 billion in Q2 2025 and a floor of $2.1 billion in Q1 2022.
  • Historically, Total Liabilities has averaged $2.3 billion across 5 years, with a median of $2.2 billion in 2023.
  • Biggest five-year swings in Total Liabilities: dropped 7.03% in 2022 and later grew 21.29% in 2024.
  • Tracing IART's Total Liabilities over 5 years: stood at $2.1 billion in 2021, then decreased by 0.58% to $2.1 billion in 2022, then rose by 5.21% to $2.2 billion in 2023, then rose by 13.58% to $2.5 billion in 2024, then rose by 2.66% to $2.6 billion in 2025.
  • Business Quant data shows Total Liabilities for IART at $2.6 billion in Q4 2025, $2.6 billion in Q3 2025, and $2.6 billion in Q2 2025.